Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 228

Diageo plc Stock Outlook December 2025: Profit Warning, New CEO and What Comes Next for DGE & DEO

Diageo plc Stock Outlook December 2025: Profit Warning, New CEO and What Comes Next for DGE & DEO

Diageo shares closed at 1,729p in London on 3 December 2025, up 1.83% for the day but down 34% from their 52-week high. The company’s Q1 FY26 net sales fell 2.2% year-on-year to $4.88bn, following a November profit warning. Net debt reached $21.9bn at fiscal year-end, with leverage at 3.4x EBITDA. Some analysts now question the sustainability of Diageo’s rising dividend.
Royal Bank of Canada (RY) Stock: Record 2025 Earnings, Dividend Hike and 2026 Outlook

Royal Bank of Canada (RY) Stock: Record 2025 Earnings, Dividend Hike and 2026 Outlook

Royal Bank of Canada reported record 2025 earnings on December 3, with net income up 25% to C$20.4 billion and a dividend increase. Shares traded near all-time highs in both Toronto and New York. Analyst upgrades followed the results and auditor confirmation of financial health. The bank’s integration of HSBC Canada contributed to a 28% year-to-date stock gain.
3 december 2025
Macy’s (M) Stock Slips After Surprise Q3 Profit and Raised 2025 Outlook: What Investors Need to Know Today

Macy’s (M) Stock Slips After Surprise Q3 Profit and Raised 2025 Outlook: What Investors Need to Know Today

Macy’s reported a surprise third-quarter profit and its strongest comparable sales growth in over three years, but shares fell 0.7% to $22.55 after management issued a cautious holiday outlook. Net sales reached $4.71 billion, down 0.6% year-over-year but above analyst estimates. Adjusted EPS came in at $0.09, beating expectations for a loss. The stock remains near its 52-week high.
CrowdStrike (CRWD) Stock on December 3, 2025: Q3 Earnings Beat, AI Tailwinds and New Wall Street Targets

CrowdStrike (CRWD) Stock on December 3, 2025: Q3 Earnings Beat, AI Tailwinds and New Wall Street Targets

CrowdStrike reported Q3 FY2026 revenue of $1.23 billion, up 22% year-over-year, and raised its outlook after another earnings beat. Shares traded near $515 late December 3, 2025, down slightly after opening lower and rebounding from an intraday low of $487. The company posted record annual recurring revenue of $4.92 billion and record free cash flow of $296 million. GAAP net loss widened to $34 million.
Procter & Gamble (PG) Stock Today: CFO Warning Knocks Shares Near 2‑Year Low as Wall Street Eyes 15–20% Upside

Procter & Gamble (PG) Stock Today: CFO Warning Knocks Shares Near 2‑Year Low as Wall Street Eyes 15–20% Upside

Procter & Gamble shares fell as much as 3.3% on December 3, 2025, after CFO Andre Schulten warned of sharply lower U.S. sales in October and likely November. The stock traded near $146, close to its two-year low, as Schulten cited weaker demand and pressure on lower-income shoppers. Despite the warning, management reaffirmed full-year guidance following solid Q1 results.
3 december 2025
DoorDash (DASH) Stock Rallies as $100 Million Insider Bet and Analyst Upgrades Clash With Amazon’s 30‑Minute Delivery Push

DoorDash (DASH) Stock Rallies as $100 Million Insider Bet and Analyst Upgrades Clash With Amazon’s 30‑Minute Delivery Push

DoorDash shares traded around $222 Wednesday afternoon, up sharply from November lows but still 20% below October’s peak. The stock briefly jumped over 3% intraday after renewed analyst optimism and heavy insider buying, following a volatile month of earnings-driven swings, regulatory headlines, and Amazon’s new ultra-fast delivery test. Market value hovered near $94 billion.
3 december 2025
Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol shares traded at $139–140 on December 3, 2025, valuing the company near $171 billion after a 102% year-to-date total return. Q3 sales jumped 53% to $6.2 billion, with diluted EPS up 102% year over year, driven by AI datacenter demand and acquisitions. The stock trades at a trailing P/E of about 52, well above industry averages. Analysts describe the valuation as “stretched.”
3 december 2025
Astera Labs (ALAB) Stock Rebounds After NVLink Fusion Shock: December 3, 2025 News, Forecasts and AI Outlook

Astera Labs (ALAB) Stock Rebounds After NVLink Fusion Shock: December 3, 2025 News, Forecasts and AI Outlook

Astera Labs shares rebounded 6% to $151 Wednesday after plunging 13% the previous day on concerns Amazon’s new AI partnership with NVIDIA could threaten Astera’s role in AWS hardware. The drop followed news that Amazon will use NVIDIA’s NVLink Fusion in next-gen Trainium 4 accelerators. Analysts and management said Astera’s components remain relevant, easing investor fears.
Vertiv (VRT) Stock on December 3, 2025: AI Cooling Leader, S&P 500 Speculation and Fresh Wall Street Forecasts

Vertiv (VRT) Stock on December 3, 2025: AI Cooling Leader, S&P 500 Speculation and Fresh Wall Street Forecasts

Vertiv Holdings shares traded near $179.16 in late trading December 3, down about 1% but close to record highs after a 60% six-month surge. The stock has nearly tripled since 2023, outpacing the tech sector. Vertiv trades at a trailing P/E in the high 60s, with forward estimates near 43. Zacks named Vertiv “Bull of the Day” and reiterated a Strong Buy rating.
Coca-Cola (KO) Stock on December 3, 2025: Dividend King Faces Lawsuits, Tariffs and M&A Pause as Wall Street Sees Double‑Digit Upside

Coca-Cola (KO) Stock on December 3, 2025: Dividend King Faces Lawsuits, Tariffs and M&A Pause as Wall Street Sees Double‑Digit Upside

Coca-Cola closed at $70.81 on December 3, 2025, up 0.2%, with a market cap of $304.6 billion and a 2.88% dividend yield. Q3 net revenue rose 5% to $12.5 billion, with EPS up 30% to $0.86. The stock remains below its 52-week high of $74.38. Management cited a challenging environment but reported gains in market share and premium brands.
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen shares closed at $345.42 on December 3, 2025, up 2% and setting a new 52-week high near $345.95. The stock has gained about 35% year-to-date and over 25% in the past year. Amgen beat Q3 earnings forecasts and raised full-year guidance, but analysts’ 12-month targets mostly remain below current prices. The consensus rating ranges from “Hold” to “Moderate Buy.”
Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

Home Depot shares closed at $357.91 on December 3, up 1.1% but 18% below last year’s high. The company beat Q3 sales estimates but missed on profit and cut its full-year outlook. Heavy call option activity followed, along with shareholder fraud probes by law firms. Home Depot also announced a $2.30 dividend and expanded its Instacart partnership in Canada.
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific (BSX) closed at $98.57 on December 3, down slightly, with shares trading in a $97.60–$99.30 range. EVP Arthur Butcher sold 17,313 shares on December 1 for about $1.76 million under a pre-arranged plan. The stock is up roughly 8–9% over the past year but remains about 9.6% below its September high. The company also received new European device approvals this week.
4 december 2025
Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Accenture shares closed at $272.85 on Dec. 3, up 4.5% but still 30% below their 52-week high. Fiscal 2025 revenue beat forecasts at $17.6 billion, with record AI-related bookings, though 2026 guidance projects only 2–5% growth. New AI partnerships with OpenAI and Snowflake are expanding. Institutions continue to buy, while insiders sold over 33,000 shares in recent months.
Yangzijiang Shipbuilding (SGX: BS6) Stock: December 4, 2025 Price, Order Book, Analyst Forecasts and Key Risks

Yangzijiang Shipbuilding (SGX: BS6) Stock: December 4, 2025 Price, Order Book, Analyst Forecasts and Key Risks

Yangzijiang Shipbuilding shares traded at S$3.42–3.43 Thursday morning in Singapore, up over 30% in the past year after rebounding from a sharp sell-off triggered by US port-fee threats. The stock remains below analyst targets despite a record order book and a trailing P/E of about 9–10. US and China suspended new port fees in November, easing immediate risks for Chinese shipyards. Market cap stands near S$13.4 billion.
4 december 2025
AI Technology Today, December 4, 2025: Regulation Tightens, New Frontier Models Emerge, and AI Infrastructure Becomes the New Arms Race

AI Technology Today, December 4, 2025: Regulation Tightens, New Frontier Models Emerge, and AI Infrastructure Becomes the New Arms Race

The European Union has launched an antitrust investigation into Meta over its integration of Meta AI into WhatsApp, focusing on potential abuse of dominance and data practices. Italy’s competition authority opened a parallel probe. A new report finds major AI labs fall short of global safety standards. In the US, a draft executive order would block state-level AI regulations in favor of a national approach.
Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast, Inc. traded at $35.17 per share with a market cap of $20.68 billion in early December 2025. JPMorgan upgraded the stock to Overweight with a $43 target on December 4, while UBS reiterated a Buy rating and $50 target the same day. BNP Paribas Exane raised its rating to Outperform with a $40 target on December 1. The stock’s valuation remains high, with a trailing P/E in the high-70s to low-80s.
1 226 227 228 229 230 279
Go toTop